FDA Approved Medical Products for:

Respiratory distress syndrome, infant

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Pulmonary surfactant replacement, porcine
Trade Name
(Manufacturer Name)
Curosurf®
(Cornerstone Therapeutics Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment (rescue) of respiratory distress syndrome in premature infants.
More Information about this product Drug Information Portal

Generic Name Colfosceril palmitate, cetyl alcohol, tyloxapol
Trade Name
(Manufacturer Name)
Exosurf Neonatal for Intratracheal Suspension
(Glaxo Wellcome Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of established hyaline membrane disease at all gestational ages.
More Information about this product Drug Information Portal

Generic Name Surface active extract of saline lavage of bovine lungs
Trade Name
(Manufacturer Name)
Infasurf®
(Forest Laboratories, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.
More Information about this product Drug Information Portal

Generic Name Beractant
Trade Name
(Manufacturer Name)
Survanta intratracheal suspension
(Abbott)
Indication
The FDA has approved this product to be used in this manner.
Treatment of ("rescue") of premature infants with RDS confirmed by x-ray and requiring mechanical ventilation.
More Information about this product Drug Information Portal